| Status | In progress |
| Technology type | Diagnostic |
| Decision | Selected |
| Reason for decision | Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources |
| Process | EVA |
Project Team
| Project lead | Toni Gasse |
Email enquiries
- If you have any queries please email diagnostics@nice.org.uk
| External Assessment Group | Centre for Reviews and Dissemination and Centre for Health Economics, University of York |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 09 May 2024 | In progress. Updated to EVA from DG |
| 09 May 2024 | There has been an additional delay to the draft guidance consultation for the Early Value Assessment: Artificial intelligence (AI) technologies for assessing skin lesions referred on the urgent suspected cancer pathway being circulated. Please accept our apologies, the website will be updated with any new consultation dates in due course. |
| 18 January 2024 | Committee meeting |
| 25 October 2023 | Scope published |
| 18 October 2023 | Scoping workshop |
| 05 September 2023 - 03 October 2023 | Specialist committee member recruitment |
| 05 September 2023 | Launch |
| 24 August 2023 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on our processes and methods, please see our early value assessment interim statement.